On the one hand, ATF6 protects β cells from ER stress, inhibits hepatic steatosis, and reduces hyperglycemia and hyperinsulinemia in obese mice with hepatic overexpression (41); on the other hand, ATF6 is also involved in the development of hyperlipidemia and insulin resistance (42). Here, ATF6 is linked to hyperlipidemia.